The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma.
 
Cindy M. Pabon
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Brian D. Badgwell
Consulting or Advisory Role - AstraZeneca
 
Paul F. Mansfield
Stock and Other Ownership Interests - Amgen; LabCorp; Stryker
Patents, Royalties, Other Intellectual Property - Royalties for up to date
 
Naruhiko Ikoma
No Relationships to Disclose
 
Matheus Sewastjanow-Silva
No Relationships to Disclose
 
Jeffrey H. Lee
No Relationships to Disclose
 
Manoop S. Bhutani
No Relationships to Disclose
 
Brian Weston
No Relationships to Disclose
 
Emmanuel Coronel
No Relationships to Disclose
 
Grace L. Smith
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - Varian Medical Systems (I)
Other Relationship - Oncora Medical (I)
 
Emma Holliday
No Relationships to Disclose
 
Jessie Tian
No Relationships to Disclose
 
Prajnan Das
Employment - MD Anderson Cancer Center
Honoraria - Bayer
Consulting or Advisory Role - American Society for Radiation Oncology
 
Bruce D. Minsky
No Relationships to Disclose
 
Rebecca E Waters
Consulting or Advisory Role - Astellas Pharma
 
Jeannelyn Estrella
No Relationships to Disclose
 
Jenny Jing Li
No Relationships to Disclose
 
Jaffer A. Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Pharmaceuticals; Fresenius Kabi; Gilead Sciences; GRAIL; Lilly; Merck; Novartis; oncotherics; SERVIER; zymeworks
Consulting or Advisory Role - American Cancer Society; Amgen; Arcus Biosciences; Astellas Pharma; BeiGene; BeiGene; Bristol-Myers Squibb; Geneos; Gilead Sciences; Insys Therapeutics; Merck; Novartis; SERVIER; Vaccinogen
Research Funding - Amgen; Astellas Pharma (Inst); Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
 
Mariela A. Blum Murphy
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)